Relypsa is a biopharmaceutical company leading the discovery, development and commercialization of polymer-based medicines to treat conditions that are often overlooked and undertreated, but that can have a serious impact on patient lives or even be life-threatening. We are focused on developing medicines that will change treatment paradigms.
Relypsa was founded in October 2007 and is headquartered in Redwood City, Calif. In September 2016, Relypsa became a Vifor Pharma company. Learn more about Vifor Pharma
Vifor Fresenius Medical Care Renal Pharma and Relypsa announce Submission of Marketing Authorisation Application Requesting European Approval of Patiromer for treatment of hyperkalemia
Soho Flordis International signs an agreement for the acquisition of Potters and the Equazen(TM) brand portfolio from Vifor Pharma
Vifor Fresenius Medical Care Renal Pharma: Expansion of product portfolio and establishment of a marketing and sales organisation in Europe
Our Mission
For Medical Information, Drug Safety Adverse Event Reports and/or Product Quality Complaints:
KEY FACTS ABOUT VIFOR PHARMA, INC.
-
US Businesses
-
Companies in Florida
-
Broward County Companies
- Company name
- VIFOR PHARMA, INC.
- Status
- Active
- Filed Number
- F15000005435
- FEI Number
- 26-0893742
- Date of Incorporation
-
December 9, 2015
Age - 10 years
- Home State
- DE
- Company Type
- Foreign for Profit
CONTACTS
- Website
- http://relypsa.com
- Phones
-
(650) 421-9500
(844) 735-9772
(844) 835-8277
VIFOR PHARMA, INC. NEAR ME
- Principal Address
- 1000 First Ave,
Suite 300,
King of Prussia,
PA,
19406,
US
See Also